JP Morgan Raises PT On Catalyst Health Solutions To $66

JP Morgan has raised the price target on Catalyst Health Solutions CHSI from $60 to $66 and maintains its Overweight rating.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Price TargetAnalyst Ratingscatalyst health solutionsHealth CareHealth Care ServicesJP Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!